These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22541650)

  • 1. Enhanced circulating soluble LR11 in patients with diabetic retinopathy.
    Takahashi M; Bujo H; Shiba T; Jiang M; Maeno T; Shirai K
    Am J Ophthalmol; 2012 Jul; 154(1):187-92. PubMed ID: 22541650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
    Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
    Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.
    Shiba T; Bujo H; Takahashi M; Sato Y; Jiang M; Hori Y; Maeno T; Shirai K
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2689-95. PubMed ID: 23652469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
    Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
    Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
    Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
    Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
    Berk KA; Vongpromek R; Jiang M; Schneider WJ; Timman R; Verhoeven AJ; Bujo H; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2016 Nov; 254():67-72. PubMed ID: 27697674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
    Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
    Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating soluble LR11 in patients with acute coronary syndrome.
    Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
    Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
    Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
    Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
    Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.
    Sugita Y; Ohwada C; Kawaguchi T; Muto T; Tsukamoto S; Takeda Y; Mimura N; Takeuchi M; Sakaida E; Shimizu N; Tanaka H; Abe D; Fukazawa M; Sugawara T; Aotsuka N; Nishiwaki K; Shono K; Ebinuma H; Fujimura K; Bujo H; Yokote K; Nakaseko C
    Clin Chim Acta; 2016 Dec; 463():47-52. PubMed ID: 27725222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.
    Ishida H; Jiang M; Ebinuma H; Hiruta N; Schneider WJ; Kinoshita T; Bujo H
    Clin Chim Acta; 2019 Oct; 497():172-177. PubMed ID: 31299181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
    Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.
    Hashimoto R; Jiang M; Shiba T; Hiruta N; Takahashi M; Higashi M; Hori Y; Bujo H; Maeno T
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):885-891. PubMed ID: 28102455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.
    Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H
    Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
    Mohan A; Saxena S; Kaur A; Ali W; Akduman L
    Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
    Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
    Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum erythropoietin concentration and its correlation with stage of diabetic retinopathy.
    Davidović S; Babić N; Jovanović S; Barišić S; Grković D; Miljković A
    BMC Ophthalmol; 2019 Nov; 19(1):227. PubMed ID: 31727007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
    Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
    Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.